To study the impact of neonatal resuscitation program (NRP) guidelines on delivery room (DR) management of infants born through meconiumstained amniotic fluid (MSAF).
INTRODUCTION
The incidence of live born babies delivered through meconium stained amniotic fluid (MSAF) is approximately 10 to 13%. [1] [2] [3] [4] [5] The rate of meconium aspiration (MA) in these infants is reported to be between 5 and 12%. 1, [3] [4] [5] [6] Traditional intrapartum measures for prevention of MA have included nasal/oropharyngeal suctioning by obstetricians and pediatricians, followed by direct tracheal suctioning through endotracheal intubation (INT). The risk/ benefit ratio of the latter has been a source of controversy.
A recent prospective multicenter study found no benefit to routine tracheal suctioning in vigorous infants born through MSAF. 1 Subsequently in 2000, the neonatal resuscitation program (NRP) guidelines 7, 8 were modified from routine INT based on consistency of meconium (i.e., thick), to selective INT for tracheal suctioning for only babies who are nonvigorous at birth. The objective of this study was to investigate whether these year 2000 NRP guidelines changed the delivery room (DR) management or outcome of these babies born through MSAF.
METHODS

Patient Population
This is a retrospective study conducted at a single teaching institution with an obstetric volume of approximately 4000 births per year among an urban and a suburban population. This institution is associated with a level III Neonatal Intensive Care Unit (NICU).
The obstetrical practice at our institution is to suction the oro/nasopharynx of each baby born through MSAF with either a catheter attached to the wall suction set at 80 to 120 mmHg vacuum or by bulb syringe before delivery of the infant's shoulder or trunk. These deliveries are attended by either a mid-level practitioner (MLP: neonatal nurse practitioner or a physician assistant), a neonatal fellow or by a senior pediatric resident. The publication of the multicentered randomized trial 1 in January 2000 led to a change in practice recommendations in our hospital such that the indication for tracheal suctioning changed from meconium consistency to infant vigor. This change was discussed broadly with the NICU physicians, mid-level practitioners and residents rotating through the NICU.
For intratracheal suctioning we use Kurtis s meconium aspirators with uniform suctioning for 2 to 5 seconds while withdrawing the tube. Babies are reintubated until the intratracheal suctioning is clear of the meconium unless severe bradycardia (heart rate <60 beats per minute) warrants positive pressure ventilation.
Design
The inclusion criteria were (1) presence of meconium in the amniotic fluid and (2) gestational age (GA) Z37 weeks. Infants with major congenital abnormalities including major cardiac defects were excluded. We reviewed the DR computerized records of all infants noting meconium consistency (thin, moderate or thick), APGAR scores and intrapartum interventions. At our institution, medical record documentation of all DR resuscitations is handwritten on preformatted flow sheets, shortly after delivery and prior to transfer of the infant to the NICU or newborn nursery. The information from the duplicate copies was entered into a computerized DR database. Infants subsequently admitted to the NICU had a detailed chart review including review of pertinent chest X-rays. We classified babies whose 1-minute APGAR score was between 8 and 10 as ''vigorous'' and those with 1-minute APGAR scores between 0 and 7 as ''nonvigorous''.
Infants who were born through MSAF and subsequently admitted to the NICU were categorized into two groups: (1) MA: those with respiratory distress (RD) >24 hours and a chest X-ray typical of aspiration (coarse irregular infiltrates, hyperinflation, segmental or lobar atelectasis, patchy consolidation), (2) RD-other : those with RD <24 hours or a chest X-ray consistent with an alternative diagnosis (e.g., TTN, pneumonia). The radiological evidence of MA on CXR was based on either the radiologist's or attending neonatologist's comments. Since our main objective of the study was to compare the effects of the year NRP guidelines on the DR management or outcome of babies born through MSAF, we divided our study population into two periods of 3 years each: period 1: January 1, 1997 to December 31, 1999 (before NRP 2000 guidelines published); and period 2: January 1, 2000 to December 31, 2002 (after NRP 2000 guidelines published).
Data were analyzed using w 2 tests and logistic regression analysis. IRB approval for this study was obtained at Hartford Hospital, CT, USA.
RESULTS
There were 12,927 live births born at Z37 weeks GA in period 1 and 11,718 live births born at Z37 weeks GA in period 2. The proportion of infants born through MSAF was 13.6% in period 1 and 13.1% in period 2 ( p ¼ NS). The character of the meconium was the same in both groups (thin 49%; moderate 23%, thick 28%). Nonreassuring fetal heart rate tracing was documented in 5.2% of babies in period 1 vs 5.7% of babies in period 2 ( p ¼ NS). The proportion of babies with a 1-minute APGAR of 8 to 10 (''vigorous'') was 76% in period 1 and 72% in period 2 ( p ¼ NS).
The overall INT rate in period 1 was 67% compared to 41% in period 2 ( p<0.001). INT rates for infants based on the meconium consistency are shown in Figure 1 .
INT rates declined in all subgroups of meconium consistency in period 2 compared to period 1 ( p<0.001 in all subgroups). Similarly, INT rates declined for both vigorous and nonvigorous infants ( p<0.001) (Figure 2) . We further analyzed the factors contributing to the decision to intubate in the DR using step-wise multiple logistic regression analysis. The factors significant were APGAR 0 to 7 (nonvigorous infants) (OR: 3.34; CI: 2.75 to 4.05), thickness of meconium (thick meconium vs thin) (OR: 4.8; CI: 3.9 to 5.9) and period 2 vs period 1 (OR: 0.27; CI: 0.23 to 0.32). Among infants born through MSAF, the incidence of MA was 0.85% (n ¼ 15) in period 1 and 1.3% (n ¼ 20) in period 2 ( p ¼ NS). The incidence of RD-other was 1.9% (n ¼ 33) in period 1 and 1.4% (n ¼ 22) in period 2 ( p ¼ NS). In total, 48 (2.75%) infants developed respiratory symptoms in period 1 vs 42 (2.7%) in period 2 ( p ¼ NS). For the subgroup of vigorous infants (1-minute APGAR 8 to 10) the incidence of MA and RD-other was 0.89% in period 1 vs 0.69% in period 2 ( p ¼ NS). Using stepwise logistic regression, the following factors were predictive of the development of MA or RD-other: nonvigorous (APGAR 0 to 7 at 1-minute of age) (OR: 5.25; CI: 3.16 to 8.71), born through thick MSAF (OR: 2.09, CI: 1.32-3.31) and the presence of meconium below the cords (OR: 2.74; CI: 1.59 to 4.71). Of note, in this analysis, the period of birth was not an independent predictor of the development of either MA or RD-other. The number of babies requiring mechanical ventilation in the study population remained the same (n ¼ 10) in both periods ( p ¼ NS). No infant required ECMO, one baby in each period was treated with inhaled nitric oxide and there were no deaths.
DISCUSSION
The main findings of this study are that a more selective approach to DR tracheal suctioning for the infant born through MSAF was adopted in period 2 as compared to period 1 and that this change in DR practice was not associated with any significant difference in the incidence of MA or nonspecific RD. To our knowledge, this is the first study examining the impact of the year 2000 NRP guidelines on practice and outcome. Our results support the newer recommendations. INT rates were reduced in all meconium subgroups and for vigorous (1-minute APGAR 8 to 10) and nonvigorous (1-minute APGAR 0 to 7) newborns.
In the last few decades, significant changes have taken place in the DR management of babies born through MSAF. In the mid1970s, a protocol combining obstetrical suctioning of the infant's oro/nasopharynx followed by routine tracheal suctioning by the pediatrician was developed and was widely accepted.
9,10 Subsequent reductions in the incidence and severity of MA supported the efficacy of this approach. However, as a few investigators noted, INT and intratracheal suctioning was not completely beneficial and had potential complications such as bradycardia, hypoxemia, reduced 1-minute APGAR score, perforation of larynx or pharynx, dislocation of vocal cords, hoarseness or stridor and apnea.
11
The controversy surrounding the best approach for the vigorous infant with meconium staining was recently addressed by a randomized prospective study by Wiswell et al. 1 Based on the results of this multicenter study showing no benefit to routine tracheal suctioning in this group of newborns, a selective approach was recommended by the NRP in the most recent 2000 guidelines. This study lends further support to these guidelines.
The incidence of MA and nonspecific RD in our population of infants born through MSAF in both period 1 (0.85%) and in period 2 (1.3%) is within the range of published figures (0.28 to 5.8%), 12, 13 but lower than that reported in the recent study of Wiswell et al. 1 Potential explanations include differences in patient population, study design (prospective vs retrospective; single vs multiple institution study; and type of meconium suction device employed, Kurtis s vs Neotech s ). The potential risk of a selective approach is an increase in MA. Our study is consistent with previous reports documenting no significant increase in the rate of MA or other respiratory complications following a selective approach to tracheal suctioning. 1, [14] [15] [16] [17] [18] [19] [20] [21] Although there was an insignificant trend toward more MA in period 2 (1.3%) compared to period 1 (0.85%) ( p ¼ NS), this was offset by a reduction in incidence of RD-other in period 2 (1.4%) compared to period 1 (1.9%) ( p ¼ NS). Further, there was no change in the rate of MA or RD-other in the sub-group of ''vigorous'' infants. Finally, the period of birth was not a significant predictor of illness in the multiple regression analysis.
The results of this study should be interpreted in the light of its limitations. As a retrospective study, we used APGAR of 8 to 10 as a proxy for the definition of vigor in the NRP 2000 guidelines (HR >100 beats per minute, good respiratory effort and a reasonable muscle tone within the first 15 seconds of life). It is likely that some discordance exists and may explain the small but significant decline in INT rates for the nonvigorous group. Alternatively, it is possible that the new guidelines of non-INT for the vigorous infants were inappropriately applied to some nonvigorous infants as well. Although we found no difference in respiratory outcome between both periods, it is possible that studies of larger populations might detect a subtle but significant effect of DR INT on outcome.
In conclusion, endotracheal INT for suctioning in infants born through MSAF should be reserved for babies who are nonvigorous at birth as recommended in the NRP 2000 guidelines. However, further surveillance in large populations should continue to assess the safety and efficacy of this approach.
